Table 4.
OR | 95% CI | P - value | |
---|---|---|---|
Age | 1·093 | 1·063 - 1·125 | < 0·001 |
Hypertension | 4·29 | 2·492 - 7·384 | < 0·001 |
Atrial fibrillation | 13·007 | 4·208 - 4·206 | < 0·001 |
Diabetes mellitus | 2·751 | 1·440 - 5·268 | 0·002 |
Anticoagulation | 8·374 | 3·165 - 22·145 | < 0·001 |
β-blocker | 5·73 | 2·518 - 10·043 | < 0·001 |
ACE inhibitor/ARB | 4·552 | 2·298 - 9·018 | < 0·001 |
Statins | 4·154 | 1·771 - 9·741 | 0·001 |
Metfomin | 3·679 | 1·486 - 9·106 | 0·005 |
Laparoscope | 0·481 | 0·261 - 0·887 | 0·019 |
Lee score≥2 | 4·55 | 1·501 - 13·791 | 0·007 |
NEUR | 1·022 | 1·012 - 1·032 | < 0·001 |
LDL | 0·571 | 0·404 - 0·807 | 0·002 |
Hs - cTnI>0·028 ng/ml | 14 | 7·8 - 25·3 | < 0·001 |
LVEF | 0·939 | 0·906 - 0·973 | < 0·001 |
LA | 1·082 | 1·027 - 1·140 | 0·003 |
IVS | 1·255 | 1·071 - 1·471 | 0·005 |
LVPW | 1·426 | 1·193 - 1·705 | < 0·001 |
Univariate logistic regression analyses of various variables as a predictor for the combined endpoint of mortality, acute myocardial infarction, cardiac arrest or ventricular fibrillation, and acute decompensated heart failure. ACEI, Angiotensin-converting enzyme inhibitor; ARB, Angiotensin receptor blocker; NEUR, neutrophil granulocyte ratio; LDL, low density lipoprotein; hs-cTnI, high sensitive-cardiac troponin I; LVEF, left ventricular ejection fraction; LA, left atrium; IVS, interventricular septum; LVPW, left ventricular posterior wall. Depicted are all variables with a P - value < 0·1.